Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(CRL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/22/2021 11/23/2021 11/24/2021 11/26/2021 11/29/2021 Date
374.85(c) 369.98(c) 377.51(c) 375.28(c) 375.31 Last
382 971 394 741 383 042 192 276 211 610 Volume
-1.32% -1.30% +2.04% -0.59% +0.01% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 3 522 M - -
Net income 2021 358 M - -
Net Debt 2021 2 484 M - -
P/E ratio 2021 53,7x
Yield 2021 -
Sales 2022 3 925 M - -
Net income 2022 487 M - -
Net Debt 2022 2 018 M - -
P/E ratio 2022 39,8x
Yield 2022 -
Capitalization 18 940 M 18 940 M -
EV / Sales 2021 6,08x
EV / Sales 2022 5,34x
Nbr of Employees 18 400
Free-Float 98,3%
More Financials
Company
Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA... 
More about the company
Ratings of Charles River Laboratories International, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
11/24Altitude Chairman To Retire; Successor Named
MT
11/16Charles River Laboratories to Participate in Upcoming Investor Conferences
BU
11/16Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $409 ..
MT
11/12CHARLES RIVER LABORATORIES PROMOTES BIRGIT GIRSHICK TO CHIEF OPERATING OFFICER - Form 8..
PU
11/12CHARLES RIVER LABORATORIES INTERNATI : Change in Directors or Principal Officers, Financia..
AQ
11/11Charles River Laboratories Names Birgit Girshick Chief Operating Officer
MT
11/11Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer
BU
11/11Charles River Laboratories International, Inc. Promotes Birgit Girshick to Chief Operat..
CI
11/10Charles River Laboratories Reinforces Commitment to South Carolina
CI
11/09Charles River Laboratories Mulls M&A
CI
11/09Charles River Laboratories International, Inc. at Credit Suisse 30th Annual Healthcare ..
PU
11/09CHARLES RIVER LABORATORIES INTERNATI : Regulation FD Disclosure (form 8-K)
AQ
11/05Bit Bio Limited announced that it expects to receive funding from a group of investors
CI
11/04Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $465..
MT
11/03CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Management's Discussion and Analysis of..
AQ
More news
News in other languages on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
11/24Le président d'Altitude prend sa retraite ; son successeur est nommé
11/11Charles River Laboratories nomme Birgit Girshick directrice de l'exploitation
11/03Charles River Laboratories annonce des résultats plus élevés au troisième trimestre et ..
11/03Earnings Flash (CRL) Les LABORATOIRES CHARLES RIVER INTERNATIONAL affichent un chiffre ..
11/03Charles River Laboratories International, Inc. révise ses prévisions de bénéfices pour ..
More news
Analyst Recommendations on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
More recommendations
Stock Trading Strategies
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - 2020
The underlying trend is to the upside
BUY
More Stock Trading Analysis
Chart CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Duration : Period :
Charles River Laboratories International, Inc. Technical Analysis Chart | CRL | US1598641074 | MarketScreener
Technical analysis trends CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 375,31 $
Average target price 427,08 $
Spread / Average Target 13,8%
EPS Revisions
Managers and Directors
James C. Foster Chairman, President & Chief Executive Officer
David Ross Smith Chief Financial Officer & Executive Vice President
Arthur C. Hubbs Chief Information Officer & Senior Vice President
Birgit Girshick Chief Operating Officer
Matthew L. Daniel Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.50.20%18 938
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.81%24 431